BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Medetalibeyoglu A, Emet S, Kose M, Akpinar TS, Senkal N, Catma Y, Kaytaz AM, Genc S, Omer B, Tukek T. Serum Endocan Levels on Admission Are Associated With Worse Clinical Outcomes in COVID-19 Patients: A Pilot Study. Angiology 2021;72:187-93. [PMID: 32969233 DOI: 10.1177/0003319720961267] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Chenevier-gobeaux C, Ducastel M, Meritet J, Ballaa Y, Chapuis N, Pene F, Carlier N, Roche N, Szwebel T, Terrier B, Borderie D. Plasma Endocan as a Biomarker of Thrombotic Events in COVID-19 Patients. JCM 2022;11:5560. [DOI: 10.3390/jcm11195560] [Reference Citation Analysis]
2 Gaudet A, Ghozlan B, Dupont A, Parmentier-Decrucq E, Rosa M, Jeanpierre E, Bayon C, Tsicopoulos A, Duburcq T, Susen S, Poissy J. Derivation and Validation of a Predictive Score for Respiratory Failure Worsening Leading to Secondary Intubation in COVID-19: The CERES Score. J Clin Med 2022;11:2172. [PMID: 35456266 DOI: 10.3390/jcm11082172] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Alay H, Laloglu E. Can Endocan Be a Novel Marker in the Diagnosis of Brucellosis? Vector-Borne and Zoonotic Diseases. [DOI: 10.1089/vbz.2021.0103] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Akpek M. Does COVID-19 Cause Hypertension? Angiology 2021;:33197211053903. [PMID: 34889662 DOI: 10.1177/00033197211053903] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
5 Kweon OJ, Cha MJ, Baek MS, Choi SH, Kim WY. Biomarkers Associated with Failure of Liberation from Oxygen Therapy in Severe COVID-19: A Pilot Study. J Pers Med 2021;11:974. [PMID: 34683115 DOI: 10.3390/jpm11100974] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Keskinidou C, Vassiliou AG, Zacharis A, Jahaj E, Gallos P, Dimopoulou I, Orfanos SE, Kotanidou A. Endothelial, Immunothrombotic, and Inflammatory Biomarkers in the Risk of Mortality in Critically Ill COVID-19 Patients: The Role of Dexamethasone. Diagnostics (Basel) 2021;11:1249. [PMID: 34359331 DOI: 10.3390/diagnostics11071249] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
7 Görgün S, Cindoruk Ş, Özgen E, Yadigaroğlu M, Demir MT, Yücel M, Akpınar ÇK, Güzel M. Diagnostic and Prognostic Value of Serum Endocan Levels in Patients With COVID-19. Angiology 2021;:33197211026044. [PMID: 34180269 DOI: 10.1177/00033197211026044] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Domínguez-Alemán CA, Sánchez-Vargas LA, Hernández-Flores KG, Torres-Zugaide AI, Reyes-Sandoval A, Cedillo-Barrón L, Remes-Ruiz R, Vivanco-Cid H. Dengue Virus Induces the Expression and Release of Endocan from Endothelial Cells by an NS1-TLR4-Dependent Mechanism. Microorganisms 2021;9:1305. [PMID: 34203931 DOI: 10.3390/microorganisms9061305] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Goldman M, Hermans C. Thrombotic thrombocytopenia associated with COVID-19 infection or vaccination: Possible paths to platelet factor 4 autoimmunity. PLoS Med 2021;18:e1003648. [PMID: 34029337 DOI: 10.1371/journal.pmed.1003648] [Cited by in Crossref: 6] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
10 Pascreau T, Tcherakian C, Zuber B, Farfour E, Vasse M, Lassalle P. A high blood endocan profile during COVID-19 distinguishes moderate from severe acute respiratory distress syndrome. Crit Care 2021;25:166. [PMID: 33957951 DOI: 10.1186/s13054-021-03589-3] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
11 Balta Ş. COVID-19 and Endocan Levels. Angiology 2021;72:209. [PMID: 33086860 DOI: 10.1177/0003319720965817] [Cited by in F6Publishing: 1] [Reference Citation Analysis]